June 4, 2009 - Toshiba Medical Visualization Systems announced two releases in its Voxar 3D product line: Voxar 3D 6.3.2 Workstation and Voxar 3D 6.3.2 ActiveX.
Toshiba said the products are the most widely-used advanced visualization solutions for PACS, offering a rapid time-to-market with the most commonly-used advanced visualization features. Voxar 3D Workstation is an application that offers the features through in-class integration with PACS, and Voxar 3D ActiveX, a software component, offers them embedded into PACS. Designed for easy implementation and support, both systems operate on standard PACS platforms.
Voxar 3D Workstation has a full, enterprise-wide integration with PACS. It uses the PACS worklist, so users can access advanced visualization with one mouse click. It also shares data in memory with PACS, loading series at five times the speed of a traditional DICOM transfer, the company said. The series is then available to Voxar 3D Workstation immediately; reloading over a workstation or network is not necessary.
PACS stores captures as live images, increasing efficiency by allowing advanced visualization to be saved and resumed throughout the workflow.
Voxar 3D ActiveX has all the integration benefits of Voxar 3D Workstation along with deeply-embedded integration. With Voxar 3D ActiveX, Voxar 3D views are embedded and controlled within the PACS user interface. PACS customers do not need to jump between applications, and they require less training because buttons are familiar to them. The features also look consistent with the rest of the system. Toshiba said Voxar 3D was the world’s first advanced visualization product line to be integrated in PACS. Since then, it has always operated on COTS hardware and standard operating systems – with Voxar 3D 6.3.2 Workstation and ActiveX, it now works with Microsoft Vista. By operating on standard PACS platforms, the Voxar 3D product line allows PACS customers to use existing IT infrastructure and existing supplier arrangements.
For more information: www.tmvse.com
May 16, 2024 
